InvestorsHub Logo
Followers 16
Posts 951
Boards Moderated 0
Alias Born 02/01/2018

Re: None

Sunday, 02/11/2018 8:05:31 PM

Sunday, February 11, 2018 8:05:31 PM

Post# of 64411
For over five years, one patient with AMN using RPI-78M under the compassionate release laws of the United Kingdom has maintained an improved quality of life that provides us with quiet confidence for this new study," said Rik Deitsch, chairman and CEO of Nutra Pharma Corporation. "We expect this trial to be the first in a series of Phase II human clinical trials anticipated to begin over the next several months.,"
Only 1 I was hoping for more than that